The HbA1c/HDL-C ratio as a screening indicator of NAFLD in U.S. adults: a cross-sectional NHANES analysis (2017–2020)

Table 7 ROC analysis of identifying NAFLD

	AUC	95%CI	Specificity	Sensitivity	Delong P-value
HbA1c/HDL-C	0.713	(0.700-0.726)	0.627	0.693
HDL-C	0.676	(0.662–0.690)	0.594	0.664	<0.01^a
HbA1c	0.664	(0.650–0.678)	0.783	0.471	<0.01^b
FLI	0.804	(0.793–0.815)	0.731	0.723	<0.01^c
TyG	0.717	(0.704–0.730)	0.693	0.626	0.52^d
HSI	0.696	(0.683–0.709)	0.772	0.523	0.05^e
NHHR	0.665	(0.652–0.679)	0.672	0.587	<0.01^f
NHR	0.654	(0.640–0.668)	0.661	0.578	<0.01^g

Abbreviations: AUC: area under the receiver operating characteristic curve; CI: Confidence interval
^a compare with HDL-C (Delong test); ^b compare with HbA1c (Delong test); ^c compare with FLI (Delong test); ^d compare with TyG (Delong test); ^e compare with HSI (Delong test); ^f compare with NHHR (Delong test); ^g compare with NHR (Delong test)

ISSN: 1471-230X